1. Bouhnik Y, Carbonnel F, Laharie D, Stefanescu C, Hébuterne X, Abitbol V, Nachury M, Brixi H, Bourreille A, Picon L, Bourrier A, Allez M, Peyrin-Biroulet L, Moreau J, Savoye G, Fumery M, Nancey S, Roblin X, Altwegg R, Bouguen G, Bommelaer G, Danese S, Louis E, Zappa M, Mary J-Y (2018) Efficacy of adalimumab in patients with Crohn’s disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 67(1):53–60
2. British National Formulary (2019) Celecoxib.
https://bnf.nice.org.uk/drug/celecoxib.html
. Accessed 11th December 2019
3. Chen J, Li J, Li R, Wang H, Yang J, Xu J, Zha Z (2017) Efficacy and safety of Tanezumab on osteoarthritis knee and hip pains: a meta-analysis of randomized controlled trials. Pain Med 18(2):374–385
4. Colloca L, Benedetti F (2007) Nocebo hyperalgesia: how anxiety is turned into pain. Curr Opin Anaesthesiol 20(5):435–439
5. De Vecchis R, Baldi C, Di Biase G, Ariano C, Cioppa C, Giasi A, Valente L, Cantatrione S (2014) Cardiovascular risk associated with celecoxib or etoricoxib: a meta-analysis of randomized controlled trials which adopted comparison with placebo or naproxen. Minerva Cardioangiol 62(6):437–448